Advertisement Quick-Med wins FDA clearance for Nimbus barrier gauze - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Quick-Med wins FDA clearance for Nimbus barrier gauze

Quick-Med Technologies, a life sciences company, has received clearance from the FDA to market and distribute its patented Nimbus barrier gauze wound care dressings.

According to the company, this represents the first FDA clearance for Nimbus – a technology that is so unique and that it was put through FDA’s de novo process.

Anticipating FDA clearance, Quick-Med has already licensed Nimbus gauze for marketing in the US and Canada to Derma Sciences, a provider of advanced wound care products. Derma Sciences and the company expect the product to launch in spring, 2009.

The company is actively negotiating with other medical device manufacturers for application of nimbus to other substrates.